Your session is about to expire
← Back to Search
Study Summary
This trial is testing whether the immune response to the vaccine is the same in people in the US as it is in people in India, and whether people who have already received a different vaccine have a different response.
- COVID-19
- Coronavirus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are 18 years of age or older.You have a history of or currently have an autoimmune disease that needs treatment. This includes conditions like rheumatoid arthritis, multiple sclerosis, or lupus.You are allergic to any ingredients in the study vaccine.You had a major illness, surgery, or injury within the past 4 weeks before starting the study.You have a serious medical condition that may make it unsafe or difficult for you to participate in the study.You must not have taken the influenza vaccine within 4 months of the second dose of vaccination.You have a bleeding disorder or a condition that causes prolonged bleeding, and the doctor thinks it is not safe to give you an injection in the muscle.You have had a serious allergic reaction, such as anaphylaxis, to a vaccine or any part of the study treatment.
- Group 1: BBV152
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many study participants are helping to test this new medication?
"The information available on clinicaltrials.gov verifies that this research is still looking for volunteers. The trial was initially advertised on February 20th, 2022 and updated for the last time on August 30th of the same year. In total, 400 individuals are needed to complete the study at 9 different locations."
Is this trial being conducted in numerous hospitals throughout the state?
"Currently, this trial is taking place in 9 locations which include Dallas, Tempe and Winter Park. If you are considering enrolling in the trial, please pick a clinic that is most convenient for you to attend to minimize travel requirements."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger